Evaluation and Management of Secondary Hypertension
- PMID: 35227430
- PMCID: PMC9728017
- DOI: 10.1016/j.mcna.2021.11.004
Evaluation and Management of Secondary Hypertension
Abstract
Hypertension is a major cause of cardiovascular morbidity and mortality globally. Many patients with hypertension have secondary causes of hypertension that merit further evaluation. For example, secondary hypertension can result in target organ damage to the heart, kidneys, and brain independent of the effects of blood pressure. Several causes benefit from targeted therapies to supplement first-line antihypertensive agents. However, secondary hypertension is often underrecognized. The goal of this review is to highlight optimal approaches to the diagnosis and management of common causes of secondary hypertension, including primary aldosteronism, renovascular hypertension, obstructive sleep apnea, and drug-induced hypertension.
Keywords: Blood pressure; Hypertension; Obstructive sleep apnea; Primary aldosteronism; Renal artery stenosis; Resistant hypertension; Secondary hypertension.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure All authors report no relevant disclosures. Dr J.B. Cohen is supported by the National Institutes of HealthNational Heart, Lung, and Blood InstituteK23-HL133843 and R01-HL153646, National Center for Advancing Translational SciencesU01-TR003734, National Institute of Diabetes and Digestive and Kidney DiseasesR01-DK123104and U24-DK060990 and American Heart Association Bugher Award.
References
-
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. - PubMed
-
- Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41–50. - PubMed
-
- Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889–1916. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical